Summary
Daiichi Sankyo Company Ltd (Daiichi Sankyo) is a holding company that carries out the research, development, manufacture, and marketing of pharmaceutical products. The company offers a wide range of prescription drugs, over-the-counter (OTC) drugs, and quasi-drugs. The company classified its business operations into two segments, namely, Daiichi Sankyo Group segment and Ranbaxy Group segment. The company markets its products directly through its Japanese and global group companies. Daiichi Sankyo sells its products in more than 50 countries through a large network of medical representatives. The company operates across North America, South America, Europe and Asia Pacific. Daiichi Sankyo is headquartered in Tokyo, Japan.
Daiichi Sankyo Company Ltd (4568) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Daiichi Sankyo Company Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Daiichi Sankyo Company Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Daiichi Sankyo Company Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Daiichi Sankyo Company Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Daiichi Sankyo Company Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Daiichi Sankyo Company Ltd, Medical Equipment, Deal Details 11
Venture Financing 11
Ambit Biosciences Raises US$7.07 Million In Venture Financing 11
Ambit Biosciences Secures US$30 Million In Series D-2 Financing 11
Partnerships 13
Daiichi Sankyo Partners with Nitto Denko 13
Daiichi Sankyo Enters Into Co-Development Agreement With Terumo For Intradermal Vaccine 14
Debt Offering 15
Daiichi Sankyo to Raise USD713.4 Million in Public Offering of 0.81% 5th Series Bonds Due 2036 15
Daiichi Sankyo to Raise USD237.8 Million in Public Offering of 1.2% 6th Series Bonds Due 2046 15
Acquisition 16
Daiichi Sankyo Completes Acquisition Of Plexxikon 16
Daiichi Sankyo Company Ltd - Key Competitors 19
Key Employees 20
Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 26
Strategy And Business Planning 26
Feb 24, 2017: Daiichi Sankyo Announces Organizational Restructuring Effective as of April 1, 2017 26
Feb 15, 2017: Daiichi Sankyo Strengthens Authorized Generic Business through Daiichi Sankyo Espha 28
Feb 10, 2017: Daiichi Sankyo Announces Further Reorganization of its Research & Development Structure 30
Mar 31, 2016: Daiichi Sankyo Announces 5-year Business Plan (FY 2016 - FY 2020) 31
Mar 31, 2016: Daiichi Sankyo Announces Closure of Daiichi Sankyo Chemical Pharma Hiratsuka Plant 32
Feb 09, 2016: Daiichi Sankyo Announces Further Reorganization of its Research & Development Structure 33
Corporate Communications 34
Feb 24, 2017: Daiichi Sankyo Appoints New Group Corporate Officers 34
Jan 31, 2017: Daiichi Sankyo Announces New Chairman and President 35
Sep 06, 2016: Daiichi Sankyo Announces New Global Head of Development 36
Jun 30, 2016: FTSE Russell Selects Daiichi Sankyo for FTSE4Good Global Index 37
May 12, 2016: Daiichi Sankyo Announces Changes to Representative Director and Members of the Board 38
Legal and Regulatory 39
May 06, 2016: The outcome of arbitration proceeding with certain former shareholders of Ranbaxy 39
Other Significant Developments 40
Jan 10, 2017: Daiichi Sankyo Announces Reorganization of Research & Development System 40
Aug 23, 2016: Daiichi Sankyo Selects Veeva Vault to Streamline Submissions, eTMF, and Quality Management 41
Feb 24, 2016: Daiichi Sankyo Announces Organizational Restructuring as of April 1, 2016 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43
List of Tables
Daiichi Sankyo Company Ltd, Medical Equipment, Key Facts, 2016 1
Daiichi Sankyo Company Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Daiichi Sankyo Company Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Daiichi Sankyo Company Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Daiichi Sankyo Company Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Daiichi Sankyo Company Ltd, Deals By Market, 2011 to YTD 2017 9
Daiichi Sankyo Company Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Ambit Biosciences Raises US$7.07 Million In Venture Financing 11
Ambit Biosciences Secures US$30 Million In Series D-2 Financing 11
Daiichi Sankyo Partners with Nitto Denko 13
Daiichi Sankyo Enters Into Co-Development Agreement With Terumo For Intradermal Vaccine 14
Daiichi Sankyo to Raise USD713.4 Million in Public Offering of 0.81% 5th Series Bonds Due 2036 15
Daiichi Sankyo to Raise USD237.8 Million in Public Offering of 1.2% 6th Series Bonds Due 2046 15
Daiichi Sankyo Completes Acquisition Of Plexxikon 16
Daiichi Sankyo Company Ltd, Key Competitors 19
Daiichi Sankyo Company Ltd, Key Employees 20
Daiichi Sankyo Company Ltd, Subsidiaries 22
List of Figures
Daiichi Sankyo Company Ltd, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Daiichi Sankyo Company Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Daiichi Sankyo Company Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Daiichi Sankyo Company Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Daiichi Sankyo Company Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Daiichi Sankyo Company Ltd, Medical Equipment, Deals by Type, 2011 to YTD 2017 7
Daiichi Sankyo Company Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Daiichi Sankyo Company Ltd, Medical Equipment, Deals by Market, 2011 to YTD 2017 9
